AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
2.15% (0.97%) (2.40%) (6.11%)

+8 more TTM periods

Piotroski F-Score
8 7 6 6
ROA
1.64% (0.74%) (1.81%) (4.60%)
ROIC
1.92% (0.44%) (1.48%) (4.11%)
Return on Tangible Assets
3.45% (1.64%) (4.09%) (10.95%)
Average Days of Receivables
51.25 47.14 45.51 44.35
Free Cash Flow per Share
1.09 1.11 1.01 0.69
Free Cash Flow
53.11 53.64 48.28 33.00
Capital Expenditures
(11.82) (10.72) (9.05) (10.14)
Other line items
Cash ROIC
7.03% 7.56% 6.59% 4.73%
Accounts Receivable Turnover
7.80 8.20 8.42 8.79
Accounts Payable Turnover
4.39 4.83 5.31 4.55
Inventory Turnover
1.68 1.73 1.74 1.68
Average Days of Payables
96.92 82.81 69.07 71.38
Days of Inventory on Hand
226.89 219.88 214.20 221.25
Tax Rate
(0.13) 0.41 0.13 0.03
Research and Development Expense of Revenue
17.21% 18.28% 18.56% 21.16%
Selling, General and Administrative Expense of Revenue
56.82% 57.87% 58.19% 58.82%
Share Based Compensation of Revenue
8.30% 8.39% 8.36% 8.45%
Interest Coverage
2.29 (0.51) (1.61) (4.54)
Operating CF/Net income
6.15 (14.01) (5.01) (1.50)
Depreciation/Fixed assets
0.50 0.53 0.54 0.52
Capex/Depreciation
(0.55) (0.51) (0.43) (0.49)
Revenue per Share
11.70 11.42 11.19 10.82
Operating CF per Share
1.33 1.33 1.20 0.90
Capex per Share
(0.24) (0.22) (0.19) (0.21)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates